A patient’s genomic profile, integrated with real-world and evidence-based data, supports clinicians in delivering more targeted therapies and individualized treatments.
A patient’s genomic profile, integrated with real-world and evidence-based data, supports clinicians in delivering more targeted therapies and individualized treatments.
Our solutions enable confident healthcare decisions and ultimately help healthcare organizations drive clinical, operational and financial value.
Oncology Hub provides clinicians with the right information at the right time, through a holistic view of the patient’s journey.
Tumor Board standardizes processes across the institution’s various tumor boards to:
Apps provide real-time access to health data and clinical evidence, enabling more informed treatment decisions and improved patient care. Our ecosystem of apps is continually evolving to support more confident treatment decisions.
Guidelines for Tumor Board
Assists in decision-making with convenient access to the most recent National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
Clinical Trial Match* for Tumor Board
Increases treatment options by identifying clinical trials relevant to individual patients
Publication Search* for Tumor Board
Brings the latest medical and scientific literature to the forefront, providing oncology teams with the most relevant information available for decision-making
Mutation Profiler is a clinical next-generation sequencing (NGS) reporting solution that helps labs and clinicians:
Understand treatment options supported by local drug approval agencies, clinical studies and medical guidelines
Filter and identify clinical trial opportunities based on a patient’s genomic alterations.
Mutation Caller is a cloud-based secondary analysis solution with next-generation sequencing variant calling methods to support the Roche KAPA portfolio of Sample Prep Reagents. Now, labs can:
As a component of Digital Pathology, Roche uPath enterprise software seamlessly enables communication between pathologists and technicians via usability, innovation and digitization.
Pass enables point-of-care providers to deliver test results to test recipients wherever they are, using mobile devices on the HIPAA- and GDPR-aligned navify Platform.
portfolio is a suite of cloud-based Software as a Service (SaaS) solutions designed to keep sensitive patient data safe and accessible to healthcare providers and specialists.
Care teams can access diverse data from a single cloud-based dashboard to help inform their decisions and help improve collaboration with specialists anytime, anywhere.
References & notes
* Powered by MolecularMatch, Inc.
** Mutation Profiler is CE-IVD. In the US, Mutation Profiler is Research Use Only (RUO). Not for use in diagnostic procedures or decisions.
*** Product not commercially available and only for evaluation in the US. For research use only and not for use in diagnostic procedures.
**** For use ONLY by individuals over the age of 18.
† Depends on connection speed
Find us
Roche Information Solutions
Roche Molecular Systems, Inc.
2881 Scott Blvd
Santa Clara, CA 95050
